Characterization of lassa virus cell entry inhibitors: determination of the active enantiomer by asymmetric synthesis (scientific article published on 03 May 2009)

Q51044301	Design, synthesis, and X-ray structural studies of BACE-1 inhibitors containing substituted 2-oxopiperazines as P1'-P2' ligands.
Q33910319	Design, synthesis, and validation of a β-turn mimetic library targeting protein-protein and peptide-receptor interactions
Q41922323	Determining the Virus Life-Cycle Stage Blocked by an Antiviral
Q34036280	Discovery libraries targeting the major enzyme classes: the serine hydrolases
Q34198487	Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic library
Q30744558	Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor
Q35183338	Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative.
Q37912497	Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.
Q41930666	Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses
Q33779739	Novel approaches in anti-arenaviral drug development
Q90181498	SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors
Q33508324	Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation
Q36021966	Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein
Q34636037	The curious case of arenavirus entry, and its inhibition
Q39625153	Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses